Pyxis Oncology, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
PYXS Nasdaq 2830 www.pyxisoncology.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Pyxis Oncology, Inc.

3 Promising Penny Stocks With Market Caps Up To $300M - Jan 7th, 2026 11:05 am
Wall Street Set to Open Higher Thursday as Inflation Rises Less Than Expected; Jobless Claims Decline - Dec 18th, 2025 7:23 am
Investors Await Key Inflation, Employment Data as US Futures Rise Thursday Pre-Bell - Dec 18th, 2025 6:15 am
Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma - Dec 18th, 2025 5:00 am
3 Promising Penny Stocks With Over $90M Market Cap - Dec 9th, 2025 5:05 am
Pyxis Oncology And 2 Other Promising Penny Stocks To Watch - Nov 4th, 2025 5:05 am
Pyxis Oncology to Participate in Upcoming Investor Conferences - Nov 3rd, 2025 2:05 pm
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results - Nov 3rd, 2025 5:00 am
Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics - Oct 15th, 2025 4:19 am
Pyxis Oncology (PYXS) Upgraded to Strong Buy: Here's What You Should Know - Oct 14th, 2025 10:00 am
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - Oct 14th, 2025 8:57 am
Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings - Oct 13th, 2025 2:05 pm
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets - Oct 9th, 2025 5:30 am
Kaltura Leads The Charge With Two Other Noteworthy Penny Stocks - Oct 6th, 2025 6:05 am
Pyxis Oncology, Inc.'s (NASDAQ:PYXS) top owners are retail investors with 39% stake, while 21% is held by institutions - Oct 2nd, 2025 12:16 pm
Maxion Therapeutics Appoints Joel Edwards as Chief Business Officer - Oct 1st, 2025 6:18 am
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 30th, 2025 2:24 pm
Should You Buy Pyxis Oncology, Inc. (PYXS) After Golden Cross? - Sep 15th, 2025 7:55 am
September 2025's Promising Penny Stock Opportunities - Sep 5th, 2025 12:04 pm
Pyxis Oncology to Participate in September Investor and Industry Conferences - Aug 21st, 2025 5:30 am